Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

Share Price is delayed by 15 minutes
Get Live Data
14,318.00    256.00 (1.82%)
Bid:
14,256.00
Ask:
14,262.00
Spread: 6.00 (0.042%)
Market Cap: £222.05b
AZN Live PriceLast checked at - London Stock Exchange

Intraday Astrazeneca Share Chart

Astrazeneca News

Healthcare, real estate losses drag UK shares; Fed in focus
7 May 2025

Healthcare, real estate losses drag UK shares; Fed in focus

US, UK make headway on trade pact, British official says *

LONDON MARKET CLOSE: FTSE 100 ends winning run ahead of Fed rate call
7 May 2025

LONDON MARKET CLOSE: FTSE 100 ends winning run ahead of Fed rate call

(Alliance News) - The FTSE 100 ended a 16-day winning streak on Wednesday, ahead of interest rate decisions in the US and UK, weighed by weak pharmace...

London close: FTSE snaps 16-day win streak ahead of Fed
7 May 2025

London close: FTSE snaps 16-day win streak ahead of Fed

(Sharecast News) - London stocks ended lower on Wednesday, with the top-flight index snapping a 16-day winning streak as investor caution ahead of the...

LONDON MARKET MIDDAY: Stocks decline before central bank decisions
7 May 2025

LONDON MARKET MIDDAY: Stocks decline before central bank decisions

(Alliance News) - Stock prices in London were weaker on Wednesday, with some pre-Federal Reserve decision nerves and geopolitical tensions hurting sen...

GSK, AstraZeneca slide after FDA unveils new vaccine lead
7 May 2025

GSK, AstraZeneca slide after FDA unveils new vaccine lead

(Sharecast News) - Shares in GSK and AstraZeneca came under pressure on Wednesday, after vaccine-sceptic Vinay Prasad was appointed to a key role at t...

AstraZeneca touts positive trial data for breast cancer treatment
7 May 2025

AstraZeneca touts positive trial data for breast cancer treatment

(Alliance News) - AstraZeneca PLC on Wednesday said it has received positive high-level results from its latest trial evaluating Enhertu in patients w...

AstraZeneca receives 'positive high-level results' results from Enhertu trial
7 May 2025

AstraZeneca receives 'positive high-level results' results from Enhertu trial

(Sharecast News) - Drugmaker AstraZeneca revealed on Wednesday that it had received "positive high-level results" from a Phase III trial on its specif...

LONDON MARKET OPEN: European shares struggle despite US-China hope
7 May 2025

LONDON MARKET OPEN: European shares struggle despite US-China hope

(Alliance News) - London's FTSE 100 gave back a fraction of its recent progress early Wednesday, despite some optimism on the tariff front, ahead of a...